Tenet Healthcare Corp (THC)
Industry Medical Care Facilities
This stock can be held in an Investment ISA and an Investment Account
Sell
$166.00
Buy
$172.70
$1.95 (+1.15%)
Tenet Healthcare Corp is a healthcare service provider in the US. The company operates acute-care hospitals that includes ambulatory surgery centers, diagnostic imaging centers, and urgent care centers across United States.
Prices updated at 05 Jun 2025, 23:16 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
19,179m | 18,313m | 18,479m | 17,640m | 19,485m | 19,174m | 20,548m | 20,665m | |
16,094m | 15,309m | 15,422m | 14,658m | 16,157m | 15,901m | 16,958m | 17,018m | |
1,389m | 1,607m | 1,703m | 2,140m | 2,409m | 2,412m | 2,443m | 2,917m | |
7.24 | 8.78 | 9.22 | 12.13 | 12.36 | 12.58 | 11.89 | 14.12 | |
-704m | 104m | -215m | 399m | 914m | 411m | 611m | 3,200m | |
1,797m | 2,435m | 2,155m | 2,531m | 3,666m | 3,076m | 3,388m | 6,892m | |
Sales, General and administrative | 9,274m | 8,633m | 8,698m | 8,418m | 8,878m | 8,844m | 9,146m | 8,801m |
Interest expenses | 1,028m | 1,004m | 985m | 1,003m | 923m | 890m | 901m | 826m |
Provision for income taxes | 219m | 173m | 160m | -97m | 411m | 344m | 306m | 1,184m |
Operating expenses | 14,705m | 13,702m | 13,719m | 12,518m | 13,748m | 13,489m | 14,515m | 14,101m |
Income before taxes | -101m | 629m | 320m | 671m | 1,888m | 1,345m | 1,617m | 5,248m |
Net income available to common shareholders | -704m | 104m | -215m | 399m | 914m | 411m | 611m | 3,200m |
-7 | 1.09 | -2.24 | 3.8 | 8.55 | 3.84 | 6.01 | 33.02 | |
Net interest income | -1,028m | -1,004m | -985m | -1,003m | -923m | -890m | -901m | -826m |
Advertising and promotion | - | - | - | - | - | - | - | - |
Net investment income, net | - | - | - | - | - | - | - | - |
Realised capital gains (losses), net | - | - | - | - | - | - | - | - |
Total benefits, claims and expenses | - | - | - | - | - | - | - | - |
Earnings per share (diluted) | -7 | 1.07 | -2.24 | 3.75 | 8.42 | 3.79 | 5.71 | 32.7 |
Free cash flow per share | -3.3609 | 6.509 | 2.4948 | 27.998 | 10.4303 | 2.1806 | 10.8313 | 23.9485 |
Book value/share | 0.2377 | -1.0533 | -3.2727 | -3.526 | 6.7358 | 12.0786 | 14.6473 | 40.3116 |
Debt equity ratio | - | - | - | 556.214286 | 15.088521 | 13.077058 | 9.254975 | 3.136178 |
Balance sheet
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current assets | 5,573m | 4,636m | 5,081m | 7,147m | 7,075m | 5,981m | 7,167m | 7,682m |
Current liabilities | 4,332m | 3,857m | 4,205m | 4,847m | 5,109m | 4,476m | 4,760m | 4,310m |
Total capital | 14,644m | 14,525m | 14,209m | 15,602m | 16,539m | 16,076m | 16,490m | 17,252m |
Total debt | 14,937m | 14,826m | 14,751m | 15,719m | 15,646m | 15,079m | 15,002m | 13,173m |
Total equity | -147m | -119m | -371m | 28m | 1,028m | 1,142m | 1,608m | 4,171m |
Total non current liabilities | - | - | - | - | - | - | - | - |
Loans | 14,791m | 14,644m | 14,580m | 15,574m | 15,511m | 14,934m | 14,882m | 13,081m |
Total assets | 23,385m | 22,409m | 23,351m | 27,106m | 27,579m | 27,156m | 28,312m | 28,936m |
Total liabilities | - | - | - | - | - | - | - | - |
Cash and cash equivalents | 611m | 411m | 262m | 2,446m | 2,364m | 858m | 1,228m | 3,019m |
Common stock | 101m | 103m | 104m | 106m | 107m | 102m | 100m | 95m |
Cash flow
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 716m | 611m | 411m | 262m | 2,446m | 2,364m | 858m | 1,228m |
Cash dividends paid | - | - | - | - | - | - | - | - |
493m | 432m | 563m | 2,867m | 910m | 321m | 1,623m | 1,116m | |
Investments (gains) losses | 21m | -115m | -619m | -1,608m | -714m | -808m | -969m | 3,429m |
611m | 411m | 262m | 2,446m | 2,364m | 858m | 1,228m | 3,019m | |
Net income | - | - | - | - | - | - | - | - |
1,200m | 1,049m | 1,233m | 3,407m | 1,568m | 1,083m | 2,374m | 2,047m | |
-707m | -617m | -670m | -540m | -658m | -762m | -751m | -931m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.